Operating policies and procedures reviews
Our Operating Policies and Procedures (OPP) are under regular review.
The OPP were reviewed in 2000-2001 and again in 2005. In 2012 we commenced a rolling review.
Rolling review details
In 2012 we held a discussion at the PHARMAC Forum. As a result, we produced a discussion document that sought feedback about what people thought our OPP should include.
We then produced a summary of submissions and outlined our next steps, which included our intention to create an online version of the OPP.
In 2012 we sought views on how to obtain clinical input into our hospital medical devices work and in 2013 we published an analysis of submissions.
During 2013 we consulted about our decision criteria and on policies and procedures for our hospital medical devices work.
Early in 2014 we launched a second round of consultation on our decision criteria, and began a consultation on our Named Patient Pharmaceutical Assessment policy.
As a result of feedback we received during our decision criteria review, we also released a discussion document on the topic of high cost medicines for rare disorders.
In 2014 there was more consultation on hospital medical devices.
In 2016 there were updates to reflect PHARMAC's adoption of the Factors for Consideration in place of the previous Decision Criteria, a revised Procedure for Listing a Pharmaceutical on the Pharmaceutical Schedule, and an update to section 2.1.
If you have any questions about the OPP review process, email us at email@example.com.
Last updated: 7 February 2020